RUBIFEN PROLONG 10 mg PROLONGED-RELEASE HARD CAPSULES

2. What you need to know before you or your child start taking Rubifen Prolong

Do not take Rubifen Prolong if you or your child:

• are allergic to methylphenidate or any of the other ingredients of this medicine (listed in section 6). If you think you may be allergic, consult your doctor
• have a thyroid problem
• have high eye pressure (glaucoma)
• have a tumor of the adrenal glands (pheochromocytoma)
• are taking a medicine called a monoamine oxidase inhibitor (MAOI) used for depression, or if you or your child have taken an MAOI in the last 14 days (see section "Other medicines and Rubifen Prolong")
• suffer from an eating disorder where you or your child do not feel hungry or do not want to eat (such as anorexia nervosa)
• have very high blood pressure or narrowing of the blood vessels, which may cause pain in the arms and legs
• have had heart problems, such as a history of heart attack, irregular heartbeat, chest pain, heart failure, heart disease, or heart problems
• have had a problem with the blood vessels in the brain, such as a stroke, swelling and weakening of part of a blood vessel (aneurysm), narrowing or blockage of blood vessels, or inflammation of the blood vessels (vasculitis)
• have mental health problems, such as
• • a "psychopathic personality" or "borderline personality disorder" problem
  • have abnormal thoughts or hallucinations, or a disease called "schizophrenia"
  • signs of a serious mood problem, such as:
  • • suicidal thoughts
    • severe depression (feeling sad, useless, and hopeless)
    • mania (unusual feeling of excitement, hyperactivity, or disinhibition)
    • mood changes from depression to mania

Do not take methylphenidate if you or your child have any of the above disorders. If you are not sure, talk to your doctor or pharmacist before taking methylphenidate, as this medicine may worsen these problems.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Rubifen Prolong if you or your child:

• have liver or kidney problems
• have had seizures (fits, convulsions, epilepsy) or abnormal brain tests (EEG)
• have abused or are dependent on alcohol, prescription medications, or drugs
• are women and have started menstruating (see section "Pregnancy, breastfeeding, and fertility" later)
• or if there is a family history of "tics" (difficulty controlling, repeated contractions of any part of the body, or repetition of sounds and words)
• have high blood pressure
• have a heart problem not mentioned in the "Do not take Rubifen Prolong" section
• have a mental health problem not mentioned in the "Do not take Rubifen Prolong" section. Other mental health problems include:
• • mood changes (going from manic to depressive - called "bipolar disorder")
  • experiencing aggressive or hostile behavior for the first time or worsening
  • seeing, hearing, or feeling things that do not exist (hallucinations)
  • believing things that are not real (delusions)
  • feeling unusually suspicious (paranoia)
  • feeling agitated, anxious, or tense
  • feeling depressed or guilty

Before starting treatment, tell your doctor or pharmacist if you or your child have any of the above disorders or symptoms, as this medicine may worsen these problems. Your doctor will want to monitor the effect of the medicine on you or your child.

During treatment, children and adolescents may unexpectedly experience prolonged erections. The erections can be painful and occur at any time. It is essential to contact your doctor immediately if the erection lasts more than 2 hours, especially if it is painful.

Checks that your doctor will make before you or your child start treatment with methylphenidate

These checks are to decide if methylphenidate is the right medicine for you or your child. Your doctor will discuss these aspects with you:

• any other medicine that you or your child are taking
• if you have a family history of sudden unexplained death
• any other medical problem (such as heart problems) that you, your child, or your family may have
• how you or your child feel, for example, feeling elated or depressed, having strange thoughts, or if you or your child have had these feelings in the past
• if there is a family history of "tics" (difficulty controlling, repeated contractions of any part of the body, or repetition of sounds and words)
• any mental health or behavioral problem that you or your child or other family members have or have had in the past. Your doctor will explain if you or your child are at risk of mood changes (going from mania to depression - called "bipolar disorder"). Your doctor will check your mental health history and family history of suicide, bipolar disorder, or depression

It is essential to provide as much information as possible. This information will help your doctor decide if methylphenidate is the right medicine for you or your child. Your doctor may think that you or your child need other medical tests before starting to take this medicine.

Drug tests

This medicine may give positive results in drug tests.

Effects in case of improper use as a doping agent

The use of methylphenidate may lead to positive results in doping tests.

Improper use of methylphenidate for doping purposes can put health at risk.

Other medicines and Rubifen Prolong

Tell your doctor or pharmacist if you or your child are taking, have recently taken, or might take any other medicines.

Do not take methylphenidate if you or your child:

• are taking a medicine called a monoamine oxidase inhibitor (MAOI) used to treat depression, or have taken an MAOI in the last 14 days. Taking an MAOI with methylphenidate can cause a sudden increase in blood pressure (see "Do not take Rubifen Prolong").

If you or your child are taking other medicines, methylphenidate may affect their action or cause side effects. Therefore, it may be necessary to change the dose of the medicine or stop treatment together. If you or your child are taking any of the following medicines, consult your doctor or pharmacist before taking methylphenidate:

• other medicines for depression
• medicines for severe mental health problems (such as schizophrenia)
• medicines for epilepsy
• medicines used to lower or increase blood pressure
• some cough and cold remedies whose ingredients may affect blood pressure. It is essential to consult your pharmacist when buying any of these medicines
• medicines that thin the blood to prevent clots

If you are unsure whether any of the medicines you or your child are taking are included in the above list, ask your doctor or pharmacist before taking methylphenidate.

Before an operation

Tell your doctor if you or your child are going to have an operation. You should not take methylphenidate on the day of the operation if a certain type of anesthesia is used, as there is a risk of a sudden increase in blood pressure during the procedure.

Taking Rubifen Prolong with food, drinks, and alcohol

Do not drink alcohol while taking this medicine, as alcohol may worsen its side effects. Remember that some foods and medicines contain alcohol.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.

Available data do not suggest an increased risk of total congenital anomalies, although a small increased risk of cardiac malformations during its use in the first three months of pregnancy could not be ruled out. Your doctor will provide more information about this risk.

Consult your doctor or pharmacist before using methylphenidate if you or your daughter:

• are sexually active. Your doctor will discuss contraceptive methods with you
• are pregnant or think you may be pregnant. Your doctor will decide if you should take methylphenidate
• are breastfeeding or plan to breastfeed. It is possible that methylphenidate may pass into breast milk. Therefore, your doctor will decide if you should breastfeed while taking methylphenidate.

Driving and using machines

Dizziness, drowsiness, and visual disturbances may occur during treatment with methylphenidate. If these side effects occur, it may be dangerous to perform activities that require attention (such as driving, operating machines, riding a bicycle, or climbing trees) until you are sure that you or your child are not affected.

Rubifen Prolong contains sucrose

Rubifen Prolong contains sucrose (a type of sugar). If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

3. How to take Rubifen Prolong

Follow the administration instructions for this medication exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.

Dose

Usually, your doctor will start treatment with a low dose that will be gradually increased as needed.

Children (from 6 years) and adolescents

The recommended initial dose is 20 mg once a day. According to the doctor's judgment, treatment with methylphenidate can also be initiated with a dose of 10 mg. The maximum daily dose is 60 mg. Rubifen Prolong is taken once a day in the morning in patients under 18 years of age.

Adults

• If it's the first time you're taking methylphenidate, the doctor will start treatment with a dose of 20 mg once a day and, if necessary, will gradually increase the dose in small weekly increments.
• If you have already received treatment with a modified-release methylphenidate formulation during childhood and have just turned 18, your doctor may maintain treatment at the same dose. If during childhood you were treated with an immediate-release formulation, your doctor will prescribe the equivalent dose of Rubifen Prolong.

The maximum daily dose is 80 mg.

For lower doses or smaller increments, different doses of this medication or other medications containing methylphenidate may be available.

Things your doctor will do when you or your child are under treatment

Your doctor will perform some tests:

• before you or your child start treatment: to ensure that methylphenidate is safe and beneficial (detailed in the section "Checks that your doctor will perform before you or your child start treatment with methylphenidate").
• after you or your child have started treatment: these tests will be performed at least every 6 months, but possibly more frequently. These will also be performed when the dose is changed.

These tests will include:

• appetite check
• measurement of height and weight in children
• weight measurement in adults
• measurement of blood pressure and heart rate
• check for mood problems or other unusual sensations, or if these have worsened since taking Rubifen Prolong

Method of administration

Rubifen Prolong is for oral use.

Take methylphenidate once a day in the morning. Methylphenidate should not be taken too late, as it can cause sleep disturbances.

• The capsule can be taken with or without food.
• The capsule should be swallowed whole, with a glass of water.
• Do not crush, chew, or divide the capsule or its contents.

If you or your child are unable to swallow the Rubifen Prolong capsule, you can pour the contents over a small amount of food, as follows:

• Open the capsule carefully and pour the granules over a small amount of soft food (e.g., apple sauce).
• The food should not be hot, as this could affect the special properties of the granules.
• Take the entire mixture of medication and food immediately.

Do not store any medication/food mixture for future use.

Instructions for opening the blister pack

This medication is available in child-resistant peelable blister packs with a security closure. Please follow the following instructions for opening the blister pack:

1. Do not push the capsule to remove it from the blister pack, as this will cause it to crush.
2. Take the blister pack with the printed sheet facing up and fold it back at the perforated line, fold the blister pack in the opposite direction, and repeat several times. Separate at the perforated area to obtain a dose.

1. To extract the capsule, carefully separate the sheet starting from the corner indicated with an arrow and pull it back.

Long-term treatment

Methylphenidate should not be taken for life. If the administration of methylphenidate lasts more than a year, your doctor should briefly suspend treatment at least once a year. In children, this can happen during school vacations. This will determine if the medication is still needed.

If you or your child do not feel better after 1 month of treatment

If you or your child do not feel better, inform your doctor. He may decide if you or your child need a different treatment.

Inadequate use of Rubifen Prolong

If methylphenidate is not used properly, abnormal behavior may appear. It can also mean that you or your child start to depend on the medication. Inform your doctor if you or your child have abused or are dependent on alcohol, prescription medications, or drugs.

This medication is only for you or your child. Do not give this medication to other people, even if they have similar symptoms.

If you or your child take more Rubifen Prolong than you should

If you or your child have taken more medication than you should, consult your doctor or call an ambulance immediately. Medical treatment may be necessary. You can also contact the Toxicology Information Service, phone 91 562 04 20.

Signs of overdose may include: vomiting, agitation, tremors, increased uncontrolled movements, muscle contractions, seizures (sometimes followed by coma), feeling extremely happy, confusion, seeing, feeling, or hearing things that are not real (hallucinations), sweating, flushing, headache, high fever, changes in heartbeats (slow, fast, or irregular), high blood pressure, dilated pupils, and dryness of the nose and mouth, muscle swelling, weak and sensitive muscles, muscle pain, dark urine.

If you or your child forget to take Rubifen Prolong

Do not take a double dose to make up for forgotten doses. If you or your child forget to take a dose, you should wait for the next dose at the scheduled time.

If you or your child stop treatment with Rubifen Prolong

If you or your child suddenly stop taking the medication, it is possible that the symptoms of ADHD or unwanted effects such as depression may reappear. Your doctor will recommend that you gradually reduce the amount of medication you take per day before stopping it completely. Consult your doctor before stopping methylphenidate.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them. Your doctor will discuss these side effects with you.

Some side effects could be serious. If you or your child experience any of the following side effects, inform your doctor immediately:

Common (may affect up to 1 in 10 people)

• irregular heartbeats (palpitations)
• changes in personality
• excessive teeth grinding (bruxism)

Uncommon (may affect up to 1 in 100 people)

• suicidal thoughts or feelings
• seeing, feeling, or hearing things that are not real, which are symptoms of psychosis
• uncontrolled body movements or speech (Tourette's syndrome)
• signs of allergy such as rash, itching, or hives on the skin, swelling of the face, lips, tongue, or other parts of the body, shortness of breath, difficulty breathing
• mood changes or disturbances

Rare (may affect up to 1 in 1,000 people)

• feeling exceptionally excited, more active than usual, or uninhibited (mania)

Very rare (may affect up to 1 in 10,000 people)

• heart attack
• seizures (including epilepsy with convulsions)
• skin peeling or red-purple spots
• uncontrolled muscle spasms that affect the eyes, head, neck, body, and nervous system as a result of lack of blood circulation to the brain
• paralysis or movement problems and vision problems, difficulty speaking; may be signs of problems in the blood vessels of the brain
• decrease in the number of blood cells (red blood cells, white blood cells, and platelets) that can make you more prone to infections and cause easier bleeding and bruising
• sudden increase in body temperature, very high blood pressure, and severe seizures ("neuroleptic malignant syndrome"). It is not entirely certain that this side effect is caused by methylphenidate or other medications taken in combination with methylphenidate

Unknown frequency (cannot be estimated from available data)

• unwanted recurring thoughts
• unexplained fainting, chest pain, shortness of breath (may be signs of heart problems)
• inability to control urine elimination (incontinence)
• jaw muscle spasm that makes it difficult to open the mouth (trismus)
• stuttering

Other side effects, if they become serious, inform your doctor or pharmacist:

Very common (may affect more than 1 in 10 people)

• decreased appetite
• headache
• feeling nervous
• difficulty sleeping
• nausea
• dry mouth

Common (may affect up to 1 in 10 people)

• joint pain
• fever
• abnormal hair loss or decreased hair thickness (thinner hair)
• excessive sleepiness or drowsiness
• loss of appetite
• weight loss in adults
• panic attacks
• decreased sexual desire
• toothache
• itching, rash, or red itchy patches (urticaria)
• excessive sweating
• cough, sore throat, or throat and nose irritation, difficulty breathing, or chest pain
• changes in blood pressure (mainly high blood pressure)
• rapid heartbeats (tachycardia)
• cold hands and feet
• shakes or tremors, feeling dizzy, uncontrolled movements, feeling restless
• being unusually active
• feeling aggressive, nervous, restless, anxious, depressed, stressed, irritable, and having abnormal behavior, sleep problems, and fatigue
• stomach pain, diarrhea, stomach discomfort, indigestion, thirst, and vomiting. These side effects usually occur at the start of treatment and may decrease when taking the medication with food.

Uncommon (may affect up to 1 in 100 people)

• constipation
• chest discomfort
• inflammation of the mucous membranes of the stomach and small intestine
• blood in the urine
• double vision or blurred vision
• muscle pain, muscle contractions, muscle stiffness
• increased liver test results (seen in blood tests)
• anger, restlessness, or tearfulness, excessive awareness of the environment, tension

Rare (may affect up to 1 in 1,000 people)

• changes in sexual desire
• feeling disoriented
• dilated pupils, vision problems
• breast swelling in men
• skin redness, increased skin rash redness

Very rare (may affect up to 1 in 10,000 people)

• heart attack
• sudden death
• muscle cramps
• small red spots on the skin
• inflammation or blockage of the arteries in the brain
• abnormal liver function, including liver failure and coma
• changes in test results, including liver and blood tests
• suicide attempt (including completed suicide), abnormal thoughts, lack of feelings or emotion, doing things over and over, obsessing over something
• feeling numbness in the fingers of the hands and feet, tingling, and color change from white to blue, and then to red with cold (Raynaud's phenomenon)

Unknown frequency (frequency cannot be estimated from available data)

• migraine
• very high fever
• slow, fast, or irregular heartbeats, palpitations
• major epileptic seizure ("grand mal" convulsions)
• believing things that are not true, confusion
• severe stomach pain with a feeling of discomfort and vomiting
• problems in the blood vessels of the brain (stroke, cerebral arteritis, or cerebral occlusion)
• erectile dysfunction
• prolonged, sometimes painful erections, or increased number of erections
• excessive and uncontrolled speech
• nosebleeds

Effects on growth

When used for more than a year, methylphenidate may reduce growth rate in some children. This affects less than 1 in 10 children.

• There may be a lack of weight or height gain.
• Your doctor will closely monitor height and weight, and how you or your child are eating.
• If your child is not growing as expected, treatment with methylphenidate may be suspended for a short time.

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medication Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Rubifen Prolong

Keep this medication out of sight and reach of children.

Do not use this medication after the expiration date shown on the box and blister pack after CAD. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medications should not be disposed of through wastewater or household waste. Deposit the containers and medications you no longer need at the SIGRE collection point in the pharmacy. Ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.

6. Container Content and Additional Information

Composition of Rubifen Prolong

• The active ingredient is methylphenidate hydrochloride.

Rubifen Prolong 10 mg modified-release hard capsules EFG contain 10 mg of methylphenidate hydrochloride (equivalent to 8.65 mg of methylphenidate).

Rubifen Prolong 20 mg modified-release hard capsules EFG contain 20 mg of methylphenidate hydrochloride (equivalent to 17.3 mg of methylphenidate).

Rubifen Prolong 30 mg modified-release hard capsules EFG contain 30 mg of methylphenidate hydrochloride (equivalent to 25.95 mg of methylphenidate).

Rubifen Prolong 40 mg modified-release hard capsules EFG contain 40 mg of methylphenidate hydrochloride (equivalent to 34.6 mg of methylphenidate).

Rubifen Prolong 60 mg modified-release hard capsules EFG contain 60 mg of methylphenidate hydrochloride (equivalent to 51.9 mg of methylphenidate).

• The other components are:

Capsule Content: ammonio methacrylate copolymer (type B), methacrylic acid and methyl methacrylate copolymer (1:1), povidone 30, sugar spheres (containing sucrose and corn starch), talc, triethyl citrate.

Capsule Shell: gelatin, titanium dioxide (E171).

In addition, in Rubifen Prolong 10 mg modified-release hard capsules, Rubifen Prolong 30 mg modified-release hard capsules, Rubifen Prolong 40 mg modified-release hard capsules, and Rubifen Prolong 60 mg modified-release hard capsules: Yellow Iron Oxide (E172).

Printing Ink: potassium hydroxide, propylene glycol, red iron oxide (E172), shellac, concentrated ammonia solution.

Product Appearance and Container Content

Rubifen Prolong 10 mg modified-release hard capsules EFG

Opaque hard gelatin capsule (size 2) with a dark yellow cap and a white body, printed with "RUB" in red ink on the cap and "M10" in red ink on the body, containing white and off-white pellets. Capsule length: 18 mm.

Rubifen Prolong 20 mg modified-release hard capsules EFG

Opaque hard gelatin capsule (size 2) with a white cap and a white body, printed with "RUB" in red ink on the cap and "M20" in red ink on the body, containing white and off-white pellets. Capsule length: 18 mm.

Rubifen Prolong 30 mg modified-release hard capsules EFG

Opaque hard gelatin capsule (size 2) with an ivory cap and an ivory body, printed with "RUB" in red ink on the cap and "M30" in red ink on the body, containing white and off-white pellets. Capsule length: 18 mm.

Rubifen Prolong 40 mg modified-release hard capsules EFG

Opaque hard gelatin capsule (size 1) with a dark yellow cap and a dark yellow body, printed with "RUB" in red ink on the cap and "M40" in red ink on the body, containing white and off-white pellets. Capsule length: 20 mm.

Rubifen Prolong 60 mg modified-release hard capsules EFG

Opaque hard gelatin capsule (size 0) with a dark yellow cap and an ivory body, printed with "RUB" in red ink on the cap and "M60" in red ink on the body, containing white and off-white pellets. Capsule length: 22 mm.

Child-resistant safety blisters (Aclar/PVC//Al/PET) in boxes.

Formats:

10 mg: 28, 30, 50, 56, 60, 100 capsules.

20 mg: 28, 30, 50, 56, 60, 84, 100 capsules.

30 mg: 28, 30, 50, 54, 56, 60, 100 capsules.

40 mg: 28, 30, 50, 54, 56, 60, 100 capsules.

60 mg: 28, 30, 40, 50, 56, 60, 100 capsules.

Only some pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Laboratorios Rubió, S.A.

Industria, 29. Pol. Ind. Comte de Sert

08755 Castellbisbal (Barcelona)

Spain

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Germany Methylphenidat NewLine Pharma Hartkapseln mit veränderter Wirkstofffreisetzung

Spain Rubifen Prolong modified-release hard capsules EFG

Poland Symkinet MR

Portugal Metilfenidato NewLine Pharma

Date of the last revision of this leaflet: March 2023

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)